Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparative Effectiveness and Safety of Biosimilar and Legacy Drugs

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03729674
Recruitment Status : Recruiting
First Posted : November 5, 2018
Last Update Posted : June 2, 2020
Sponsor:
Collaborators:
Université de Sherbrooke
Institut de rhumatologie de Montréal
Hospital for Special Surgery, New York
University of Manitoba
University of Toronto
University of Alberta
University of British Columbia
Alberta Health Services
McMaster University
The Arthritis Program Research Group
Information provided by (Responsible Party):
Dr. Sasha Bernatsky, McGill University Health Centre/Research Institute of the McGill University Health Centre

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 30, 2021
Estimated Study Completion Date : December 31, 2022